Loader
Loading the video
Because both pricing models tie what Medicare pays to prices charged in other countries, they could also reshape drug pricing and market strategy outside the US.

Video. US push to cut drug prices could mean longer waits for European patients

Updated:

Europe’s patients could face longer waits for some new medicines as US efforts to drive down drug prices risk encouraging pharmaceutical companies to delay launches in lower-price markets, according to a new modelling study.

Read full article
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT